The use of stimulation tests for the differential diagnosis of delayed puberty in boys. How to increase the specificity of the method?

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: In patients with a constitutional delay of puberty starts and ends completely without any medical intervention. In adolescents with hypogonadotropic hypogonadism puberty is absent or does not continue its development. Differential diagnosis of the conditions is complicated due to lack of standard recommendations for the selection, conducting and assessment of stimulation tests.

AIM: To assess the information content and find ways to increase the specificity of stimulation tests with triptorelin and corionic gonadotropin in relation to hypogonadotropic hypogonadism.

MATERIALS AND METHODS: We examined 44 adolescent boys aged 13.5–17 years with delayed puberty. Sexual development was assessed according to Tanner scale, bone age (X-ray of the non-dominant hand according to the Greulich atlas). All boys were tested with triptorelin. The test with one- and three-day intramuscular injection of human chorionic gonadotropin was performed in 26 and 35 patients, respectively. Statistical analysis was performed using the StatTech v. 2.6.1 (developer — Stattech LLC, Russia). To assess the diagnostic significance of quantitative signs in predicting a certain outcome the ROC-curve analysis was performed.

RESULTS: It was revealed that a negative test with triptorelin was observed in some patients with constitutional delay of puberty. Threshold stimulated luteinizing hormone and follicle stimulating hormone levels were set (8.90 and 5.90 IU/l respectively). Gonadotropins values equal to or lower than selected thresholds allow diagnosing of hypogonadotropic hypogonadism with high sensitivity and specificity. Threshold testosterone levels stimulated by one- and three-day administration of human chorionic gonadotropin were determined (2.11 and 5.84 nmol/l respectively). Testosterone values equal to or lower than selected thresholds allow diagnosing of hypogonadotropic hypogonadism with high sensitivity and specificity. A high degree of positive correlation was found between stimulated luteinizing hormone levels and stimulated testosterone levels during a three-day test with human chorionic gonadotropin.

CONCLUSIONS: A negative test with triptorelin is observed in some patients with constitutional delay of puberty. The specificity of the test can be improved by using threshold stimulated levels of luteinizing hormone and follicle stimulating hormone (8.90 and 5.90 IU/L, respectively). The use of the threshold levels of testosterone (2.11 and 5.84 nmol/l within the one- and three-day functional tests of the testicles respectively) can help to increase the specificity of the considered outdated stimulation tests with human chorionic gonadotropin.

Full Text

Restricted Access

About the authors

Irina Yu. Ioffe

St. Petersburg State Pediatric Medical University

Author for correspondence.
Email: ioffe.i@bk.ru

senior assistant, Department of Pediatrics them. Professor I.M. Vorontsov AF and DPO

Russian Federation, Saint Petersburg

Yulia L. Skorodok

St. Petersburg State Pediatric Medical University

Email: julia_skorodok@mail.ru

MD, PhD, Associate Professor of the Department of Pediatrics them. Professor I.M. Vorontsov AF and DPO

Russian Federation, Saint Petersburg

Elena V. Plotnikova

St. Petersburg State Pediatric Medical University

Email: miss.plotnicko@yandex.ru

MD, PhD, Associate Professor of the Department of Pediatrics them. Professor I.M. Vorontsov AF and DPO

Russian Federation, Saint Petersburg

Irena I. Nagornaya

St. Petersburg State Pediatric Medical University

Email: irena_nagornaya@mail.ru

MD, PhD, Associate Professor of the Department of Pediatrics them. Professor I.M. Vorontsov AF and DPO

Russian Federation, Saint Petersburg

Ksenia O. Nagovitsyna

St. Petersburg State Pediatric Medical University

Email: nagoksyusha@mail.ru

Resident doctor of the Department of Pediatrics them. Professor I.M. Vorontsov AF and DPO

Russian Federation, Saint Petersburg

Lyudmila A. Jelenina

St. Petersburg State Pediatric Medical University

Email: jelenina@mail.ru

MD, PhD, Dr. Med. Sci., Professor of the Department of Pediatrics them. Professor I.M. Vorontsov AF and DPO

Russian Federation, Saint Petersburg

References

  1. Dedov II, Peterkova VA, editors. Federal’nye klinicheskie rekomendatsii (protokoly) po vedeniyu detei s ehndokrinnymi zabolevaniyami. Moscow: Praktika, 2014. P. 261–266. (In Russ.)
  2. Latyshev OYu, Kiseleva EV, Okminyan GF, et al. Current tendencies in treatment of congenital hypogonadotropic hypogonadism in boys: clinical cases’ analysis. Endocrinology: News, Opinions, Training. 2020;9(2): 80–85. (In Russ.) doi: 10.33029/2304-9529-2020-9-2-80-85
  3. Liss VL, Nagornaya II, Nikolaeva LV, et al. Diagnostika i lechenie ehndokrinnykh zabolevanii u detei i podrostkov. Shabalov NP, editor. Moscow: MEDpress-inform, 2021. (In Russ.)
  4. Stroev YuI, Churilov LP. Ehndokrinologiya podrostkov. Saint Petersburg: Medkniga “EHLBI”, 2004. 384 p. (In Russ.)
  5. Khodulaeva YN, Asaulenko ZP, Baymarov AA, et al. Degenerative changes of the Medial arcuate hypothalamic nucleus neurons in the male hypogonadism model. Pediatrician (St. Petersburg). 2015;6(3):62–68. (In Russ.) doi: 10.17816/PED6362-68
  6. Binder G, Schweizer R, Blumenstock G, Braun R. Inhibin B plus LH vs GnRH agonist test for distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism in boys. Clin Endocrinol. 2015;82(1):100–105. doi: 10.1111/cen.12613
  7. Boehm U, Bouloux P-M, Dattani MT, et al. European consensus statement on congenital hypogonadotropic hypogonadism — pathogenesis, diagnosis and treatment). Nat Rev Endocrinol. 2015;11:547–564. doi: 10.1038/nrendo.2015.112
  8. Bozzola M, Bozzola E, Montalbano C, et al. Delayed puberty versus hypogonadism: a challenge for the pediatrician. Annals of Pediatric Endocrinology and Metabolism. 2018;23(2):57–61. doi: 10.6065/apem.2018.23.2.57
  9. Palmert MR, Dunkel L. Clinical practice. Delayed puberty. N Engl J Med. 2012;366:443–453. doi: 10.1056/NEJMcp1109290
  10. Kim S-H. Congenital Hypogonadotropic Hypogonadism and Kallmann Syndrome: Past, Present, and Future. Endocrinol Metab (Seoul). 2015;30(4):456–466. doi: 10.3803/EnM.2015.30.4.456

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. ROC-curve showing the realibility of hypogonadotropic hypogonadism diagnosis based on stimulated luteinizing hormone

Download (105KB)
3. Fig. 2. ROC-curve showing the realibility of hypogonadotropic hypogonadism diagnosis based on stimulated follicle stimulating hormone

Download (104KB)
4. Fig. 3. ROC-curve showing the realibility of hypogonadotropic hypogonadism diagnosis based on testosterone levels stimulated with one-day human chorionic gonadotropin test

Download (98KB)
5. Fig. 4. Roc-curve showing the realibility of hypogonadotropic hypogonadism diagnosis based on testosterone levels stimulated with three-day human chorionic gonadotropin test

Download (105KB)

Copyright (c) 2022 Ioffe I.Y., Skorodok Y.L., Plotnikova E.V., Nagornaya I.I., Nagovitsyna K.O., Jelenina L.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies